Living meta-analysis and evidence synthesis of therapies for COVID-19

click on circles to display study description...

BLAZE 4 LY-CoV1404, 0 NCT04634409

Bebtelovimab (LY-CoV1404) (n=-9) vs. placebo (n=-9)

randomized controlled trial   risk of bias NA

Studied treatment

single-dose bebtelovimab

Control treatment

placebo

Patients

COVID 19 outpatients

Method

double-blind

phase 1/2

Remark